Q32 Bio Inc. Share Price
QTTBQ32 Bio Inc. Stock Performance
Open $14.61 | Prev. Close $15.46 | Circuit Range N/A |
Day Range $14.61 - $15.95 | Year Range $1.62 - $23.38 | Volume 49,371 |
Average Traded $15.10 |
Q32 Bio Inc. Share Price Chart
About Q32 Bio Inc.
Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with autoimmune and inflammatory diseases driven by pathological immune dysfunction. The company is developing Bempikibart (ADX-914), a fully human antiinterleukin-7 receptor alpha antagonist monoclonal antibody designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7 and thymic stromal lymphopoietin for the treatment of atopic dermatitis and alopecia areata. It also develops ADX-096, a C3d mAb CR1 fusion protein for use in ophthalmologic indications, as well as other C3d mAb fusions and nanobodies designed for tissue-targeted complement inhibition. The company was founded in 2017 and is based in Waltham, Massachusetts.
Q32 Bio Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
20-Jul-26 | $14.61 | $15.05 | +0.00% |
20-Jul-26 | $14.61 | $15.05 | -0.46% |
17-Jul-26 | $15.13 | $15.12 | -0.85% |
16-Jul-26 | $15.85 | $15.25 | -2.71% |
15-Jul-26 | $18.25 | $15.68 | -15.32% |
14-Jul-26 | $21.66 | $18.51 | -13.38% |
13-Jul-26 | $17.55 | $21.37 | +90.55% |